EcoDrugPlus

Insulin Receptor-Like

Ensembl ID : ENSACLG00000021318
Gene Symbol: LOC113015984
3 Cross references
201 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSACLG00000011245
Gene Symbol: LOC113011234
3 Cross references
230 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSACLG00000019368
Gene Symbol: LOC113026105
3 Cross references
204 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSACLG00000022868
Gene Symbol: LOC113012814
3 Cross references
206 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSACLG00000001820
Gene Symbol: ITGB3A
1 Cross references
204 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSACLG00000009367
Gene Symbol: ITGB3B
1 Cross references
195 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSACLG00000001938
Gene Symbol: LOC113010138
3 Cross references
230 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSACLG00000025607
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSACLG00000024659
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSACLG00000015330
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSACLG00000011492
Gene Symbol: ITGB1
3 Cross references
209 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSACLG00000021627
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).